Beijing Beilu Pharmaceutical (300016.SZ) announced that recently, the company has passed the inspection of the Brazilian National Health Surveillance Agency (ANVISA).
Zhitong Finance APP News, Beijing Beilu Pharmaceutical (300016.SZ) announced that recently, the company has obtained the Good Manufacturing Practice (GMP) certification from the Brazilian National Health Surveillance Agency (ANVISA).
This successful ANVISA GMP certification has created conditions for the company's contrast agents to successfully enter the Brazilian market, playing a very positive role in the company's further expansion into the Brazilian market and other international markets.